Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
GSH is exclusively degraded at the extracellular level by cells expressing -glutamyltranspeptidase (GGT), such as those of the hepatobiliary tree and of other organs like the heart, kidney, lungs, pancreas, and seminal vesicles
To view or add a comment, sign in JAMA Psychiatry Editor in Chief Dost ngr, MD, PhD, explains his 2025 pick for Editors Choice: Clinical Trials of the Year
(2025, September 30)
Allison Whitten Pfizer's LITFULO meets primary endpoints in Phase 3 vitiligo trials Pfizer reported topline results from two Phase 3 trials of LITFULO (ritlecitinib) in nonsegmental vitiligo, with both the 50 and 100 milligram once-daily doses meeting co-primary endpoints for facial and total body repigmentation over placebo at Week 52
US$ 29.37
US$ 29.11
US$ 28.17
US$ 27.59
US$ 26.63
US$ 21.53
